Wound Care News and Research

RSS

Covalon second quarter revenue increases to $1,090,038

Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update.

28 May 2012

New medicine can start and hasten healing of diabetic and other chronic sores

A unique new medicine that can start and hasten healing of diabetic and other chronic sores is being developed at Umeå University in Sweden. After several years of successful experimental research, it is now ready for clinical testing.

28 May 2012

Mediaplanet publishes Wound Care

Mediaplanet Publishing, the global leader in theme media, today publishes Wound Care, an eight-page section distributed within the USA Today newspaper. Reaching over 2 million readers, the special section will appear within USA Today in the high-impact markets of New York, New England, North and South Carolina, and Southern Florida with the help of a number of industry leaders and experts.

28 May 2012

Wound Care Center Application from MedData

MedData, Inc., a leading provider of medical revenue cycle management and patient satisfaction services, announced today the launch of a new technology that streamlines the data capture and billing process for Wound Care Physicians.

24 May 2012

Proper care of diabetic foot infections can save limbs, lives

Diabetic foot infections are an increasingly common problem, but proper care can save limbs and, ultimately, lives, suggest new guidelines released by the Infectious Diseases Society of America.

23 May 2012

New evidence behind WOUNDCHEK Protease Status to be presented at EWMA conference

New evidence behind the world's first point of care wound diagnostic test, WOUNDCHEK Protease Status, to be presented at the European Wound Management Association (EWMA)'s conference in May 2012 confirms the importance of protease activity in wound healing and wound assessment, quantifies elevated protease activity (EPA), and also presents preliminary results on testing for and treating EPA in clinical practice.

22 May 2012

Derma Sciences first quarter net sales increase 6% to $15.3 million

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three months ended March 31, 2012.

15 May 2012

Celleration initiates enrollment in MIST Therapy study for VLU

Celleration, Inc., a privately-held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announced the first patient enrollment in IN-BALANCE VLU (Inflammation, Bacteria, & Angiogenesis effects in Launching Venous Leg Ulcer healing: A Clinical Evaluation).

15 May 2012

EO2 Concepts added to Marathon Medical's FSS contract

Electrochemical Oxygen Concepts, the developer of a unique and innovative chronic wound treatment device, announced it has been added to Marathon Medical's existing Federal Supply Schedule (FSS) contract, administered by The Department of Veterans Affairs.

11 May 2012

Macrocure's CureXcell Shows Strong Efficacy and Safety in Phase IV Hard-To-Heal Wounds Trial

Cell therapy demonstrates high rate of complete closure of hard-to-heal wounds, including diabetic foot (DFU) and venous ulcers.

10 May 2012

NAWC introduces Wound Care Advisor journal

National Alliance of Wound Care, the nation's largest wound care credentialing board and member association, announced today the introduction of its official journal, Wound Care Advisor.

9 May 2012

3M Health Care honored with Silver Edison Awards

Today, 3M Health Care announced it has been honored with a Silver Edison Award for Quality of Life in the Lifestyle and Social Impact category for its 3M™ Kind Removal Silicone Tape and a Silver Edison Award for Analytic Systems in the Science/Medical category for its Aerobic Procedure for Lactic Acid Bacteria with 3M Petrifilm Aerobic Count Plate. The Edison Awards, established in 1987, recognize the most innovative products in the world.

2 May 2012

Derma Sciences closes underwritten registered direct offering

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that it closed an underwritten registered direct offering of 2,125,000 shares of common stock at a price of $9.25 per share on April 5, 2012.

9 Apr 2012

FDA clears Devon Medical Products’ extriCARE 2400 NPWT system

Devon Medical Products, a global medical device designer, manufacturer, and distributor, today announced it has received Food & Drug Administration (FDA) 510(k) clearance to market its extriCARE 2400 Negative Pressure Wound Therapy (NPWT) system.

6 Apr 2012

Cardium launches Excellagen wound care product

Cardium Therapeutics today announced market introduction of its Excellagen professional-use, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers and other dermal wounds.

31 Mar 2012

Systagenix announces U.S. launch of EPIFIX amniotic membrane allograft

Systagenix, announced today that it will launch EPIFIX in the United States in March as part of a global distribution agreement reached with MiMedx Group, Inc.

21 Mar 2012

RBC Life Sciences 2011 consolidated net sales increases to $28.4 million

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated net sales of $28.4 million for the year ended December 31, 2011, a 1% increase over 2010 consolidated net sales of $28.2 million.

19 Mar 2012

New American Board of Wound Medicine and Surgery established

On October 20, 2011 the American Board of Wound Medicine and Surgery (ABWMS) was established and incorporated in the State of Ohio. The new Board, according to the President and Chairman of the Board, Richard Simman, MD, FACS, CWS, FACCWS, was established because the time has come to recognize the physician practice of wound medicine and surgery.

2 Mar 2012

WPI establishes Healthcare Delivery Institute

Worcester Polytechnic Institute (WPI) has established the Healthcare Delivery Institute, (HDI), bringing together top faculty and students in engineering, science, and business with the aim to solve one of the nation's toughest problems-delivering high-quality healthcare for a growing, aging population.

1 Mar 2012

Combined bioactive peptides successfully stimulate wound healing

Researchers have combined bioactive peptides to successfully stimulate wound healing. The in vitro and in vivo study, published today in PLoS ONE, demonstrates that the combination of two peptides stimulates the growth of blood vessels and promotes re-growth of tissue. Further development of these peptides could lead to a new treatment for chronic and acute wounds.

24 Feb 2012